| Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy L Bartalena, C Marcocci, F Bogazzi, L Manetti, ML Tanda, E Dell'Unto, ... New England Journal of Medicine 338 (2), 73-78, 1998 | 997 | 1998 |
| The effects of amiodarone on the thyroid E Martino, L Bartalena, F Bogazzi, LE Braverman Endocrine reviews 22 (2), 240-254, 2001 | 863 | 2001 |
| Role of conventional ultrasonography and color flow-doppler sonography in predicting malignancy in ‘cold’thyroid nodules T Rago, P Vitti, L Chiovato, S Mazzeo, A De Liperi, P Miccoli, P Viacava, ... European journal of endocrinology 138 (1), 41-46, 1998 | 678 | 1998 |
| Use of corticosteroids to prevent progression of Graves' ophthalmopathy after radioiodine therapy for hyperthyroidism L Bartalena, C Marcocci, F Bogazzi, M Panicucci, A Lepri, A Pinchera New England Journal of Medicine 321 (20), 1349-1352, 1989 | 410 | 1989 |
| Treatment of amiodarone-induced thyrotoxicosis, a difficult challenge: results of a prospective study L Bartalena, S Brogioni, L Grasso, F Bogazzi, A Burelli, E Martino The Journal of Clinical Endocrinology & Metabolism 81 (8), 2930-2933, 1996 | 338 | 1996 |
| Thyroid function differently affects serum cystatin Cand creatinine concentrations L Manetti, E Pardini, M Genovesi, A Campomori, L Grasso, LL Morselli, ... Journal of endocrinological investigation 28, 346-349, 2005 | 301 | 2005 |
| Approach to the patient with amiodarone-induced thyrotoxicosis F Bogazzi, L Bartalena, E Martino The Journal of Clinical Endocrinology & Metabolism 95 (6), 2529-2535, 2010 | 289 | 2010 |
| Iodide excess induces apoptosis in thyroid cells through a p53-independent mechanism involving oxidative stress M Vitale, T Di Matola, F D’Ascoli, S Salzano, F Bogazzi, G Fenzi, ... Endocrinology 141 (2), 598-605, 2000 | 289 | 2000 |
| More on smoking habits and Graves’ ophthalmopathy L Bartalena, E Martino, C Marcocci, F Bogazzi, M Panicucci, F Velluzzi, ... Journal of Endocrinological Investigation 12, 733-737, 1989 | 272 | 1989 |
| 2018 European Thyroid Association (ETA) guidelines for the management of amiodarone-associated thyroid dysfunction L Bartalena, F Bogazzi, L Chiovato, A Hubalewska-Dydejczyk, TP Links, ... European thyroid journal 7 (2), 55-66, 2018 | 266 | 2018 |
| Surgical treatment of Graves' disease: subtotal or total thyroidectomy? P Miccoli, P Vitti, T Rago, P Iacconi, L Bartalena, F Bogazzi, E Fiore, ... Surgery 120 (6), 1020-1025, 1996 | 265 | 1996 |
| Effects of amiodarone administration during pregnancy on neonatal thyroid function and subsequent neurodevelopment L Bartalena, F Bogazzi, LE Braverman, E Martino Journal of endocrinological investigation 24 (2), 116-130, 2001 | 256 | 2001 |
| Studies on the occurrence of ophthalmopathy in Graves' disease C Marcocci, L Bartalena, F Bogazzi, M Panicucci, A Pinchera European Journal of Endocrinology 120 (4), 473-478, 1989 | 250 | 1989 |
| Very-low-calorie ketogenic diet (VLCKD) in the management of metabolic diseases: systematic review and consensus statement from the Italian Society of Endocrinology (SIE) M Caprio, M Infante, E Moriconi, A Armani, A Fabbri, G Mantovani, ... Journal of endocrinological investigation 42, 1365-1386, 2019 | 243 | 2019 |
| Color flow Doppler sonography rapidly differentiates type I and type II amiodarone-induced thyrotoxicosis F Bogazzi, L Bartalena, S Brogioni, S Mazzeo, P Vitti, A Burelli, ... Thyroid 7 (4), 541-545, 1997 | 238 | 1997 |
| The various effects of amiodarone on thyroid function F Bogazzi, L Bartalena, M Gasperi, LE Braverman, E Martino Thyroid 11 (5), 511-519, 2001 | 230 | 2001 |
| Thyroid vascularity and blood flow are not dependent on serum thyroid hormone levels: studies in vivo by color flow doppler sonography F Bogazzi, L Bartalena, S Brogioni, A Burelli, L Manetti, ML Tanda, ... European journal of endocrinology 140 (5), 452-456, 1999 | 202 | 1999 |
| Amiodarone and the thyroid: a 2012 update F Bogazzi, L Tomisti, L Bartalena, F Aghini-Lombardi, E Martino Journal of endocrinological investigation 35, 340-348, 2012 | 201 | 2012 |
| Orbital radiotherapy combined with high dose systemic glucocorticoids for Graves’ ophthalmopathy is more effective than radiotherapy alone: results of a prospective randomized … C Marcocci, L Bartalena, F Bogazzi, G Bruno-Bossio, A Lepri, A Pinchera Journal of endocrinological investigation 14 (10), 853-860, 1991 | 197 | 1991 |
| A novel heterodimerization partner for thyroid hormone receptor. Peroxisome proliferator-activated receptor. F Bogazzi, LD Hudson, VM Nikodem Journal of Biological Chemistry 269 (16), 11683-11686, 1994 | 176 | 1994 |
